0.5ml Wegovy: What Volume Does Each Dose Actually Contain?

Why does the volume stay at 0.5ml when the dose keeps changing?

Pharmaceutical manufacturers often standardise the injection volume within a product range so that the delivery device (in Wegovy's case, a pre-filled auto-injector pen) can be engineered once and used consistently. Novo Nordisk chose 0.5ml as that standard volume for the Wegovy injection. What varies between the 0.25mg starter pen, the 0.5mg second-step pen, the 1mg, 1.7mg and 2.4mg pens is the concentration of semaglutide per millilitre, not the total liquid delivered.

This means the physical sensation of injecting and the needle depth remain essentially the same across your entire treatment journey. It also means the numbers you see on the label (0.5mg, 1mg, 2.4mg) describe the active medicine content, not a volume measurement. If you have been searching for information about the 0.5mg Wegovy dose specifically, that page goes into detail about what that strength is used for within the titration schedule.

The NHS medicines page for semaglutide describes the device as a pre-filled pen delivering a fixed subcutaneous dose, and the Wegovy Summary of Product Characteristics on the eMC confirms the 0.5ml injection volume throughout. Neither document suggests the volume is clinically meaningful in itself, it is the semaglutide concentration that drives the therapeutic effect.

Does the 0.5ml volume affect how I store or handle the pen?

Storage conditions for Wegovy are the same whichever strength you are on: refrigerated at 2–8°C before first use, away from the freezer compartment. Many people keep their current pen in the fridge door, though the Patient Information Leaflet is the definitive guide on the exact room-temperature window allowed once a pen has been taken out, always check that rather than relying on a general rule.

Handling-wise, the 0.5ml volume is small enough that the pen is light and straightforward to carry. Rotation of injection sites (abdomen, outer thigh or upper arm) is recommended regardless of dose step, and the fixed volume means there is no variation in how long each injection takes. If you have questions about what to expect at the 0.25ml introductory stage, that covers the starter pen in more detail.

One practical note: even though the pen volume does not change, the label and cap colour do differ between strengths. Novo Nordisk uses colour coding precisely to avoid mix-ups when more than one pen strength is in the fridge at the same time, which can happen during a dose transition.

How does the 0.5ml Wegovy pen relate to the wider dose schedule?

The licensed UK titration pathway for Wegovy moves through five steps: 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg, with each step typically held for around four weeks to allow the body to adjust and minimise gastrointestinal side effects. Each pen in that sequence contains 0.5ml of solution. The MHRA also approved a higher 7.2mg maintenance dose in January 2026, later followed by a dedicated single-dose 7.2mg pen approved on 14 April 2026, further detail on the full picture is on the Wegovy dose schedule page.

The 0.5mg strength (the second step in the schedule) is where some people become curious about the overlap between volume and strength labelling, because the number 0.5 appears in both contexts. They are different measurements: 0.5ml is a volume, 0.5mg is a weight of medicine. A page on 0.5mg semaglutide explains the clinical role of that particular rung of the ladder. For context on how the overall treatment compares and what results the STEP 1 trial reported at the 2.4mg maintenance dose, the Wegovy overview covers the evidence base alongside the STEP 1 trial published in the New England Journal of Medicine.

Titration timing and the decision to move to the next strength are always made by your prescriber, not by the calendar alone. If a dose increase causes persistent side effects, a prescriber may recommend staying at the current step for longer. The volume of each injection stays at 0.5ml throughout, it is not a variable you need to manage yourself.

Does knowing this change anything about the cost of treatment?

Not directly. Wegovy pens are priced by dose strength, not by volume. Higher-dose pens carry a higher price because the concentration of semaglutide is greater, the liquid volume is the same. If you are weighing up what private treatment costs month to month, the Wegovy cost page lays out what the private market looks like and what a transparent, all-in price actually covers: consultation, prescription, clinical review and delivery, with no separate charges added on top.

When treatment is assessed and approved through nume (sorry, through our pharmacy) a GPhC-registered Independent Prescriber reviews your consultation personally, not software, before any prescription is issued. If you are curious about eligibility or simply want to understand more before committing to anything, checking in with our prescribers is a reasonable place to start.